
"Sector" = median of Healthcare across 84 companies
National Medical Care Co. (4005) is a Saudi-based healthcare provider operating medical care facilities across the Kingdom. The company offers a comprehensive range of services including inpatient and outpatient care, surgical services, diagnostic imaging, laboratory services, and rehabilitation. It manages multiple hospitals and medical centers, focusing on delivering high-quality healthcare to patients. The company is listed on the Saudi Exchange and is part of the Healthcare sector, specifically the Medical Care Facilities industry.
Revenue is primarily generated from patient care services, including consultations, surgeries, diagnostic tests, and hospital stays. The company also earns from ancillary services such as pharmacy sales and medical supplies. Its business model relies on a mix of private payers, insurance contracts, and government agreements. The recent financials show revenue of approximately 388-412 million SAR per quarter, with net income fluctuating due to operational costs and investment in expansion.
The medical care facilities sector in Saudi Arabia is competitive, with several private and public providers. National Medical Care Co. positions itself as a quality-focused provider with a strong regional presence. Its key financial metrics include a market cap of 4.39B SAR, PE ratio of 14.88, and EV/EBITDA of 10.86, indicating moderate valuation. The company has a gross margin of 36.8% and operating margin of 22.13%, reflecting efficient operations. However, earnings declined 38.55% year-over-year, while revenue grew marginally.
The company serves a broad patient base including individuals, families, and corporate clients. Its primary geographic market is Saudi Arabia, with facilities concentrated in major cities. The target audience includes patients seeking private healthcare services, often covered by insurance or self-pay. The company also serves government-sponsored patients under certain programs. With a dividend yield of 3.05%, it appeals to income-focused investors, but the negative free cash flow yield of -4.38% suggests capital expenditure needs.
An auto-generated descriptive profile based on company data, for informational purposes only.
No 24-hour summary has been generated yet.
Latest saved period: March 2026 · 2026-03-31
Cash dividends by ex-date, not an investment recommendation.
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| May 20, 2025 | 2.00 SAR | — | — |
| May 23, 2024 | 2.00 SAR | — | — |
| Jun 20, 2023 | 1.00 SAR | — | — |
| May 18, 2022 | 1.00 SAR | — | — |
| May 30, 2021 | 1.00 SAR | — | — |
| Apr 16, 2020 | 2.00 SAR | — | — |
| Apr 24, 2019 | 1.00 SAR | — | — |
| Apr 16, 2018 | 1.00 SAR | — | — |
| Apr 28, 2016 | 0.75 SAR | — | — |
| Apr 12, 2015 | 1.55 SAR | — | — |
| Mar 18, 2014 | 1.55 SAR | — | — |
| Apr 17, 2013 | 1.45 SAR | — | — |
Wrqti brings National Medical Care Co. data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Companies in the Healthcare sector you can compare with National Medical Care Co.:
Compare National Medical Care Co. head-to-head with:
When available, the page shows quarterly and annual statements plus ratios such as PE, price to book, profit margin, and free cash flow. Latest financial period shown: March 2026.
Wrqti content depends on available data and third-party sources and may include delays or errors. Review official company filings and consult a licensed financial advisor before making investment decisions. Read the data methodology.